Winston Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.30 M
- Revenue Growth -51.54%
- Profit Growth -74.89%
- Ebitda -70.81%
- Net Worth 17.65%
- Total Assets 48.77%
About Winston Lifesciences
Winston Lifesciences Private Limited (WLPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 February 2018 (Six years and 11 months 23 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.30 M.
Nitesh Kumar, Shobita Sharma, and Talagavara Sushma serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999KA2018PTC110182
-
Company No.
110182
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Feb 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Winston Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitesh Kumar
|
Director | 16-Feb-2018 | Current |
|
Shobita Sharma
|
Director | 16-Feb-2018 | Current |
|
Talagavara Sushma
|
Director | 09-Apr-2018 | Current |
Financial Performance of Winston Lifesciences.
Winston Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 51.54% decrease. The company also saw a substantial fall in profitability, with a 74.89% decrease in profit. The company's net worth Soared by an impressive increase of 17.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Winston Lifesciences?
In 2021, Winston Lifesciences had a promoter holding of 94.00% and a public holding of 6.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.30 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 2022 | Axis Bank Limited | ₹1.30 M | Open |
How Many Employees Work at Winston Lifesciences?
Winston Lifesciences has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winston Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winston Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
